Skip to main content
. 2019 Mar 1;7(4):783–802. doi: 10.1016/j.jcmgh.2019.02.003

Figure 9.

Figure 9

Signaling pathway activity in DLD1 cells treated with CM from mesenchymal-like cancer cells. (A and B) Analysis of 45 signal transduction pathways in DLD1 cells cultured for 48 hours in CM collected from SW480/pRTR-p53-VSV cells treated with DOX (p53 on) or without DOX (p53 off) for 72 hours. (A) Complete results of the assay are shown and (B) pathways showing significant changes are shown (means ± SEM, n = 2 technical replicates). (C and D) Analysis of 45 signal transduction pathways in DLD1 cells treated with CM from SW620 cells transfected with control or NID1 siRNA. (C) Complete results of the assay are shown and (D) pathways showing significant changes are shown (means ± SEM, n = 2 technical replicates). cont, control.